SEC Comment Letter for Viewbix Inc. (VBIX) (CIK 0000797542) (QXL) — Jan 14, 2016
Viewbix Inc. (VBIX) (CIK 0000797542)
Date: Jan. 14, 2016 · CIK: 0000797542 · Accession: 0000000000-16-061407
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-206105
Letter
Mail Stop 3561 January 14, 2016 Liron Carmel Chief Executive Officer Emerald Medical Applications Corp . 7 Imber Street Petach Tivka, 4951141
Re: Emerald Medical Applications Corp . Amendment No. 3 to Registration Statement on Form S-1 Filed January 7, 2016 File No. 333-206105
Dear Mr. Carmel :
We have reviewed your amended registration statement and have the following comment . In our comment , we may ask you to provide us with information so we may better understand your disclosure.
Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comment appl ies to your facts and circumstances or do not bel ieve an amendment is appropriate, please tell us why in your response.
After reviewing any amendment to your registration statement and the information you provide in response to this comment , we may have additional comments.
Executive Compensation , page 84
1. Please revise to provide the information required by Item 402 of Regulation S -K for the fiscal year ended December 31, 2015. For guidance, refer to Question 117.05 of our Regulation S -K Compliance and Disclosure Interpretations.
Liron Carmel Emerald Medical Applications Corp January 14, 2016 Page 2
Please contact Charlie Guidry, Staff Attorney , at 202-551-3621 , Jennifer L ópez, Staff Attorney, at 202 -551-3792 , or me at 202-551-3720 with any other questions.
Sincerely,
/s/ Jennifer López for
Show Raw Text
Mail Stop 3561 January 14, 2016 Liron Carmel Chief Executive Officer Emerald Medical Applications Corp . 7 Imber Street Petach Tivka, 4951141 Re: Emerald Medical Applications Corp . Amendment No. 3 to Registration Statement on Form S-1 Filed January 7, 2016 File No. 333-206105 Dear Mr. Carmel : We have reviewed your amended registration statement and have the following comment . In our comment , we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comment appl ies to your facts and circumstances or do not bel ieve an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this comment , we may have additional comments. Executive Compensation , page 84 1. Please revise to provide the information required by Item 402 of Regulation S -K for the fiscal year ended December 31, 2015. For guidance, refer to Question 117.05 of our Regulation S -K Compliance and Disclosure Interpretations. Liron Carmel Emerald Medical Applications Corp January 14, 2016 Page 2 Please contact Charlie Guidry, Staff Attorney , at 202-551-3621 , Jennifer L ópez, Staff Attorney, at 202 -551-3792 , or me at 202-551-3720 with any other questions. Sincerely, /s/ Jennifer López for Mara L. Ransom Assistant Director Office of Consumer Products cc: Richard Rubin, Esq.